Intrathoracic fat in HIV-infected patients

HIV Medicine

Volumn 7, Issue 4, 2006, Pages 213-217

  Blanco, José Luis ^a   Biglia, A ^a   Martinez, E ^a   Sanchez M ^a   de Lazzari, E ^a   Leon, A ^a   Milinkovic, A ^a   Larrousse, M ^a   Lonca, M ^a   Laguno, M ^a   Mallolas, J ^a   Gatell, J M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

HIV infected patients; Intrathoracic fat; Lipodystrophy

Indexed keywords

ANTIRETROVIRUS AGENT;

ABDOMEN; ADULT; AGE; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EXPOSURE; FAT CONTENT; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THORAX; VOLUNTEER;

ABDOMEN; ADIPOSE TISSUE; ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; THORAX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645463972     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2006.00361.x     Document Type: Article

References (17)

1. Martinez E, Gatell JM. Metabolic abnormalities and body fat redistribution in HIV-1 infected patients: The lipodystrophy syndrome. Curr Opin Infect Dis 1999; 12: 13-19.
2. Grunfeld C. Basic science and metabolic disturbances. XIV International AIDS Conference. Barcelona, Spain, July 2002 [Abstract TuOr158].
3. Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998; 351: 871-875.
4. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. 'Buffalo hump' in men with HIV-1 infection. Lancet 1998; 351: 867-870.
5. Herry I, Bernard L, de Truchis P, Perronne C. Hypertrophy of the breasts in a patient treated with indinavir. Clin Infect Dis 1997; 25: 937-938.
6. Gaerte SC, Meyer CA, Winer-Muram HT, Tarver RD, Concces DJ. Fat-containing lesions of the chest. Radiographics 2002; 22: S61-S78.
7. Ruzicka T, Vieluf D, Landthaler M et al. Benign symmetric lipomatosis Launois-Bensaude: Report of ten cases and review of the literature. J Am Acad Derm 1987; 17: 663-674.
8. Iacobellis G, Ribaudo MC, Assael F et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: A new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003; 88: 5163-5168.
9. Martinez E, Mocroft A, Garcia-Viejo MA et al. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: A prospective cohort study. Lancet 2001; 357: 592-598.
10. Carr A, Samaras K, Burton S et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: F51-F58.
11. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary. Am J Clin Nutr 1998; 68: 899-917.
12. Van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: A practical guide. Int J Obes 1993; 17: 187-196.
13. Wajchenberg BL. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocrine Rev 2000; 21: 697-738.
14. Schejbal V. Epicardial fatty tissue of the right ventricle: Morphology, morphometry and functional significance. Pneumologie 1989; 43: 490-499.
15. Martinez E, Bianchi L, Garcia-Viejo MA, Bru C, Gatell JM. Sonographic assessment of regional fat in HIV-1-infected people. Lancet 2000; 356: 1412-1413.
16. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and the pericardium: Structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989; 94: 225-232.
17. Lauer MN, McTernan PG, Quinn DW et al. AGT, PAI and resistin gene expression in human epicardial fat. 38th Annual Meeting of the European Association for the Study of Diabetes. Budapest, Hungary, September 2000, [Abstract OP017].